Characteristics | Total No. (%) | MRSA No. (%) | MSSA No. (%) | P |
---|---|---|---|---|
Patients | 163 | 71 (43.6) | 92 (56.4) | 1.0 |
Gender | Â | Â | Â | Â |
Male | 99 (60.7) | 37 (52.1) | 62 (67.4) | 0.048 |
Female | 64 (39.3) | 34 (47.9) | 30 (32.6) | Â |
Age-Median (month, IQRa) | 6 (35.23) | 8 (35.33) | 6 (32.75) | 0.397 |
 <=1 mo | 51 (31.3) | 20 (28.1) | 31 (33.7) | 0.451 |
1 mo–1 yr | 54 (33.1) | 26 (36.6) | 28 (30.4) | 0.593 |
1 yr–3 yr | 25 (15.3) | 15 (21.2) | 10 (10.9) | 0.072 |
3 yr–14 yr | 33 (20.3) | 10 (14.1) | 23 (25) | 0.086 |
Area | Â | Â | Â | Â |
Rural | 90 (55.2) | 38 (53.5) | 52 (56.5) | 0.702 |
Urban | 73 (44.8) | 33 (46.5) | 40 (43.5) | Â |
Risk factors b: | 33 (20.2) | 23 (32.4) | 10 (10.9) | 0.001 |
history in the past 1 yr of | Â | Â | Â | Â |
 Hospitalization | 21 | 16 | 5 | 0.001 |
 Surgery | 6 | 3 | 3 | 0.336 |
 Trauma or scalds | 3 | 1 | 2 | 0.212 |
 Endotracheal intubation | 4 | 3 | 1 | 1.0 |
Congenital heart disease | 4 | 2 | 2 | 0.567 |
Other congenital diseasesc | 3 | 2 | 1 | 1.00 |
Presenting symptoms | Â | Â | Â | Â |
 Fever | 134 (82.2) | 60 (84.5) | 74 (80.4) | 0.5 |
 Hypothermia | 4 (2.5) | 2 (2.8) | 2 (2.2) | 1.00 |
 Fever days-Median (IQR) | 5.5 (7) | 6.5 (7) | 5 (6) | 0.76 |
 Shock | 4 (2.5) | 2 (2.8) | 2 (2.2) | 1.00 |
 Coma | 2 (1.2) | 1 (1.4) | 1 (1.1) | 1.00 |
Laboratory examination | Â | Â | Â | Â |
White cell count-Median (109/L IQR) | 17.35 (8.47) | 18.71 (9.41) | 16.41 (9.52) | 0.72 |
Neutrophil count-Median (IQR) | 10.46 (7.37) | 11.58 (6.44) | 10.74 (7.18) | 0.81 |
Thrombocytopenia (<100 × 109/L) | 12 (7.4) | 5 (7) | 7 (7.6) | 0.89 |
C-reactive protein-Median (mg/L, IQR) | 47.9 (19.5) | 46.7 (21.3) | 48.5 (19.3) | 0.92 |
PRISM score Median (IQR) | 2 (6) | 2 (6) | 2 (6) | 0.48 |
Hospitalization | Â | Â | Â | Â |
hospital days-median (IQR) | 15 (7) | 17 (8) | 14.5 (7) | 0.168 |
Intensive care unit (ICU) admission | 76 (46.6) | 34 (47.9) | 42 (45.7) | 0.777 |
ICU days-Median (IQR) | 9 (4) | 8 (5) | 9.5 (4) | 0.786 |